[1]
Jebamalar, S.J. and Karpagavalli, K. 2026. Formulation and Evaluation of Dolasetron Orally Disintegrating Tablets. Journal of Contemporary Medical Practice. 8, 5 (May 2026), 109–114. DOI:https://doi.org/10.53469/jcmp.2026.08(05).22.